| abstract |
The invention relates to a diphenylaminopyrimidine compound, a composition and an application. Concretely, the diphenylaminopyrimidine compound is a compound as shown in a general formula (I) described in the specification, wherein substituents in the general formula (I) are as defined in the specification. The invention also relates to the compound as shown in the general formula (I) or pharmaceutically acceptable salts thereof, or the application of a pharmaceutical composition containing the compound in treatment of tumor diseases by inhibiting Bruton's tyrosine kinase BTK and/or Janus tyrosine kinase JAK3, especially in treatment of burkitt's lymphoma, diffuse large B-cell lymphoma, follicular lymphoma or chronic lymphocytic leukemia. |